ArticleJournal of medicinal chemistry2025

Development of Selective and Soluble Mitochondrial Complex 1 Inhibitors Derived from Papaverine for Radiosensitization of Cancer.

Ben J Haines et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.